Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Cooper

Showing results (181-190 of 245) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741J Abrams, J Aisner, C Cirrincione, et al.
Leukemia & Lymphoma|February 1, 1996
Vincristine degradation by serum from leukemic patients: role of myeloperoxidaseD Schlaifer, E Duchayne, C Demur, et al.
Cancer|November 15, 1992
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVDA B Kornblith, J Anderson, D F Cella, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.
Oncology (Williston Park, N.Y.)|May 1, 1990
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trialsA B Kornblith, J Anderson, D F Cella, et al.
Seminars in Oncology|June 1, 1985
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignanciesH B Muss, R L Capizzi, J N Atkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.
Cancer|June 15, 1995
Phase I study of phenylacetate administered twice daily to patients with cancerA Thibault, D Samid, M R Cooper, et al.
American Journal of Clinical Oncology|February 1, 1984
Bone marrow evaluation in small cell lung cancerH B Muss, D V Jackson, F Richards, et al.
Pageof 25

Showing results (181-190 of 245) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741J Abrams, J Aisner, C Cirrincione, et al.
Leukemia & Lymphoma|February 1, 1996
Vincristine degradation by serum from leukemic patients: role of myeloperoxidaseD Schlaifer, E Duchayne, C Demur, et al.
Cancer|November 15, 1992
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVDA B Kornblith, J Anderson, D F Cella, et al.
Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.
American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.
Oncology (Williston Park, N.Y.)|May 1, 1990
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trialsA B Kornblith, J Anderson, D F Cella, et al.
Seminars in Oncology|June 1, 1985
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignanciesH B Muss, R L Capizzi, J N Atkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.
Cancer|June 15, 1995
Phase I study of phenylacetate administered twice daily to patients with cancerA Thibault, D Samid, M R Cooper, et al.
American Journal of Clinical Oncology|February 1, 1984
Bone marrow evaluation in small cell lung cancerH B Muss, D V Jackson, F Richards, et al.
Pageof 25